Katherine Stueland, Chief Executive Officer at GeneDx Holdings Corp. (WGS), sold 7,296 shares at $128.05 ($934K) on 2025-09-09, disclosed to the SEC on 2025-09-11.
Open-market sale of $934k WGS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $128.05 | 3,639 | $466K | 49.9% |
| 2 | $128.05 | 3,639 | $466K | 49.9% |
| 3 | $129.08 | 18 | $2K | 0.2% |
| Total | $128.05 avg | 7,296 | $934K | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |